View Older Stories View More Recent Stories

Feb 7, 2023 07:00AM New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients
Feb 1, 2023 07:03AM Bausch + Lomb Corporation (BLCO) Announce FDA Approval of ML6710i Photodynamic Laser
Feb 1, 2023 07:00AM Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)
Jan 23, 2023 07:00AM Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
Jan 17, 2023 05:12PM Bausch + Lomb Corporation (BLCO) Acquires AcuFocus
Jan 17, 2023 05:09PM Bausch + Lomb Acquires AcuFocus, Inc.
Jan 9, 2023 08:00AM Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
Jan 9, 2023 07:00AM Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
Jan 5, 2023 07:00AM Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
Jan 4, 2023 07:06AM Bausch + Lomb Corporation (BLCO) and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
Jan 4, 2023 07:00AM Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
Jan 3, 2023 07:00AM Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
Dec 22, 2022 04:00PM Bausch + Lomb Corporation (BLCO) Amends CEO Separation Agreement
Dec 22, 2022 04:00PM Bausch + Lomb Amends CEO Separation Agreement
Dec 13, 2022 07:08AM Bausch + Lomb Corporation (BLCO) Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops
Dec 13, 2022 07:00AM Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops
Dec 12, 2022 07:00AM Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly Service of the Year from Best in Biz Awards
Nov 29, 2022 09:15AM Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from Business Intelligence Group's 2022 BIG Awards for Business
Nov 15, 2022 07:00AM Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
Nov 7, 2022 07:00AM Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference
Nov 2, 2022 06:59AM Bausch + Lomb Announces Third-Quarter 2022 Results
Nov 1, 2022 09:15AM Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group
Oct 24, 2022 07:00AM Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs
Oct 18, 2022 07:00AM Bausch + Lomb Announces Presentation of Scientific Data and Analyses Evaluating Biotrue® Hydration Plus Multi-Purpose Solution at American Academy of Optometry Annual Meeting
Oct 4, 2022 07:00AM Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
Oct 3, 2022 07:00AM Bausch + Lomb Introduces Enhanced Ocuvite® Adult 50+ Eye Vitamin Formulation With Vitamin D
Sep 27, 2022 06:59AM Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress
Sep 26, 2022 06:59AM Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting
Sep 21, 2022 06:59AM Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings
Sep 13, 2022 07:00AM First Annual Bausch + Lomb Sponsored Visionary Report Spotlights Nation's 'Blind Spots' on Age-related Macular Degeneration, a Leading Cause of Vision Loss for People 50+
Sep 6, 2022 07:00AM Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane)
Sep 1, 2022 07:00AM Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments s.r.l. Intraocular Dyes
Aug 29, 2022 07:00AM Bausch + Lomb Announces Participation at Upcoming Investor Conferences
Aug 4, 2022 06:59AM Bausch + Lomb Announces Second-Quarter 2022 Results
Jul 28, 2022 08:00AM Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok
Jul 28, 2022 07:00AM Bausch + Lomb and Sanoculis Announce Strategic Agreements Designed to Address Unmet Needs in Glaucoma
Jul 26, 2022 07:00AM Bausch + Lomb Corporation (BLCO) Enrolls First Patient in Technolas TENEO Excimer Laser
Jul 26, 2022 06:59AM Bausch + Lomb Enrolls First Patient in LASIK Clinical Trial Evaluating Use of Technolas® TENEO™ Excimer Laser* for Vision Correction Surgery for Hyperopia with Astigmatism
Jul 25, 2022 07:00AM Bausch + Lomb Will Release Second-Quarter 2022 Financial Results on August 4
Jul 20, 2022 07:03AM Bausch + Lomb Corporation (BLCO) Announces Leadership Changes
Jul 20, 2022 07:00AM Bausch + Lomb Provides Leadership Update
Jul 7, 2022 07:00AM Bausch + Lomb Corporation (BLCO) and Novaliq Submit NDA for NOV03
Jul 7, 2022 06:59AM Bausch + Lomb and Novaliq Announce Submission of New Drug Application for Investigational Treatment NOV03 (Perfluorohexyloctane)
Jul 6, 2022 06:59AM Bausch + Lomb Corporation (BLCO) Reports Scientific Data on XIPERE
Jul 6, 2022 06:59AM Bausch + Lomb Announces Scientific Data on XIPERE® (Triamcinolone Acetonide Injectable Suspension) to be Presented During the American Society of Retina Specialists Annual Scientific Meeting
Jun 23, 2022 04:52PM Bausch + Lomb (BLCO) Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors
Jun 23, 2022 04:51PM Bausch + Lomb Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors
Jun 13, 2022 07:00AM Bausch + Lomb Announces the U.S. Launch of Revive™ Custom Soft Contact Lenses
Jun 8, 2022 06:59AM Bausch + Lomb Announces First-Quarter 2022 Results and Provides 2022 Guidance
Jun 6, 2022 07:00AM Bausch + Lomb Announces Scientific Data on Latest Biotrue® Products to be Presented at American Optometric Association's Optometry's Meeting
View More Recent Stories View Older Stories